Personalis, Inc. Deferred Revenue Recognized
Personalis, Inc. (PSNL) reported Deferred Revenue Recognized of $200.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-04
- Personalis, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-06-30 was $200.00K, a 60.00% decline year-over-year.
- Personalis, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $100.00K, a 90.91% decline year-over-year.
- Personalis, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-09-30 was $400.00K, a 69.23% decline year-over-year.
- Personalis, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $500.00K, a 61.54% decline year-over-year.
- Personalis, Inc. contract with customer, liability, revenue recognized for fiscal 2025 was $1.90M, a 59.57% decline from fiscal 2024.
- Personalis, Inc. contract with customer, liability, revenue recognized for fiscal 2024 was $4.70M, a 1075.00% increase from fiscal 2023.
- Personalis, Inc. contract with customer, liability, revenue recognized for fiscal 2023 was $400.00K, a 88.57% decline from fiscal 2022.
- Personalis, Inc. contract with customer, liability, revenue recognized for fiscal 2022 was $3.50M, a 81.68% decline from fiscal 2021.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $200.00K 10-Q · filed 2026-08-04 | $200.00K 10-Q · filed 2026-08-04 | ||
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $1.90M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $400.00K 10-Q · filed 2025-11-04 | $1.90M 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | $500.00K 10-Q · filed 2026-08-04 | $1.70M 10-Q · filed 2026-08-04 | ||
| 2025-03-31 | $1.10M 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $4.70M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $1.30M 10-Q · filed 2025-11-04 | $4.10M 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | $1.30M 10-Q · filed 2025-08-05 | $2.90M 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | $2.00M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $400.00K 10-K · filed 2025-02-27 | |||
| 2023-09-30 | $500.00K 10-Q · filed 2024-11-06 | $500.00K 10-Q · filed 2024-11-06 | ||
| 2022-12-31 | $3.50M 10-K · filed 2024-02-28 | |||
| 2022-09-30 | $200.00K 10-Q · filed 2023-11-07 | $3.70M 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $3.00M 10-Q · filed 2023-08-08 | $3.60M 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $2.50M 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | $19.10M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $9.70M 10-Q · filed 2022-11-02 | $19.10M 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $9.80M 10-Q · filed 2022-08-03 | $18.90M 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | $9.50M 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $33.80M 10-K · filed 2023-02-23 | |||
| 2020-09-30 | $10.60M 10-Q · filed 2021-11-04 | $31.70M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $10.80M 10-Q · filed 2021-08-04 | $21.50M 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $10.70M 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $35.40M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $10.70M 10-Q · filed 2020-11-05 | $25.20M 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $8.40M 10-Q · filed 2020-08-06 | $16.10M 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $7.80M 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $16.00M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $4.80M 10-Q · filed 2019-11-13 | $6.30M 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $500.00K 10-Q · filed 2019-08-13 | $2.00M 10-Q · filed 2019-08-13 | ||
| 2017-12-31 | $1.10M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |